LAV Summit Ltd 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 12:26 pm Sale | 2021-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | LAV Summit Ltd | 151,992 0.400% | -2,321,439 (-93.86%) | Filing |